Temporal sequence of splenic dysfunction in sickle cell disease

被引:27
作者
Adekile, AD
Owunwanne, A
Al-Za'abi, K
Haider, MZ
Tuli, M
Al-Mohannadi, S
机构
[1] Kuwait Univ, Fac Med, Dept Pediat, Safat 13110, Kuwait
[2] Kuwait Univ, Fac Med, Dept Nucl Med, Safat 13110, Kuwait
[3] Mubarak Al Kabeer, Dept Nucl Med, Kuwait, Kuwait
关键词
sickle cell disease; spleen function;
D O I
10.1002/ajh.10010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Sickle cell patients develop splenic dysfunction early in the course of their disease as shown by failure to visualize the organ on technetium-99m colloid scintigraphy. However, preliminary studies from our center have shown that, when the spleen is not demonstrable on colloid uptake, it may be visualized on technetium-99m heat-denatured RBC scintigraphy. With time, however, the spleen can no longer be visualized with both tests In many patients. We have studied 46 patients aged 2 to 16 years, which included 36 SS, 7 S beta (0) thal, and 3 SD. Eighteen (39.1%) had normal splenic colloid uptake (Group 1), 15 (32.6%) had partial uptake (Group 2), and 13 (28.3%) had absent uptake (Group 3). When the patients in Group I were compared to those in the two other groups, there was no significant dierence in the mean age and Hb F values. However, the mean Hb of 10.2 g/dl In Group 1 was significantly higher than the value of 9.0 g/dl in the other two groups. In addition, 60% of the SS patients with normal uptake and 40% of those with partial or absent uptake had co-existing alpha -thal trait; the dierence in this proportion is significant (chi (2) = 85, P < 0.0001). Heat-denatured RBC scintigraphy was carried out on five patients in Group 2, and the spleen was visible in all, while of 12 children in Group 3, the spleen was visible only in 4 patients. This study demonstrates that the phagocytic function of the spleen, which Is tested by colloid uptake, is the first to be lost while the filtration function, tested by denatured RBC uptake, persists for much longer. This finding may have significant implications for the clinical symptomatology and therapeutic strategies of sickle cell disease. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:23 / 27
页数:5
相关论文
共 23 条
[1]  
Aburano T, 1997, Ann Nucl Med, V11, P335
[2]   ALPHA-THALASSEMIA AND STROKE RISK IN SICKLE-CELL-ANEMIA [J].
ADAMS, RJ ;
KUTLAR, A ;
MCKIE, V ;
CARL, E ;
NICHOLS, FT ;
LIU, JC ;
MCKIE, K ;
CLARY, A .
AMERICAN JOURNAL OF HEMATOLOGY, 1994, 45 (04) :279-282
[3]  
Adekile AD, 1996, AM J HEMATOL, V53, P1
[4]   MOLECULAR CHARACTERIZATION OF ALPHA-THALASSEMIA DETERMINANTS, BETA-THALASSEMIA ALLELES, AND BETA(S) HAPLOTYPES AMONG KUWAITI ARABS [J].
ADEKILE, AD ;
GU, LH ;
BAYSAL, E ;
HAIDER, MZ ;
ALFUZAE, L ;
ABOOBACKER, KC ;
ALRASHIED, A ;
HUISMAN, THJ .
ACTA HAEMATOLOGICA, 1994, 92 (04) :176-181
[5]  
Adekile AD, 1996, ACTA HAEMATOL-BASEL, V96, P150
[6]   SPLEEN IN SICKLE-CELL-ANEMIA - COMPARATIVE-STUDIES OF NIGERIAN AND UNITED-STATES PATIENTS [J].
ADEKILE, AD ;
MCKIE, KM ;
ADEODU, OO ;
SULZER, AJ ;
LIU, JS ;
MCKIE, VC ;
KUTLAR, F ;
RAMACHANDRAN, M ;
KAINE, W ;
AKENZUA, GI ;
OKOLO, AA ;
ASINDI, AA ;
OBINYAN, EA ;
OGALA, WN ;
IBRAHIM, M ;
HUISMAN, THJ .
AMERICAN JOURNAL OF HEMATOLOGY, 1993, 42 (03) :316-321
[7]  
*AM INT, 1990, PROD INF AM HEP 2 TE
[8]  
ATKINS HL, 1990, J NUCL MED, V31, P378
[9]   DETECTION OF COMMON DELETIONAL ALPHA-THALASSEMIA-2 DETERMINANTS BY PCR [J].
BAYSAL, E ;
HUISMAN, THJ .
AMERICAN JOURNAL OF HEMATOLOGY, 1994, 46 (03) :208-213
[10]   HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC SEPARATION OF HUMAN HEMOGLOBINS - SIMULTANEOUS QUANTITATION OF FETAL AND GLYCATED HEMOGLOBINS [J].
BISSE, E ;
WIELAND, H .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1988, 434 (01) :95-110